IndraLab

Statements

SN-38 inhibits NFKBIA. 1 / 1

| 1

reach

"Human non small cell lung carcinoma (NSCLC-3) cells transfected with a control vector (NSCLC-3 and neo) or a vector containing dominant negative IkappaBalpha (NSCLC-3 and mIkappaBalpha) were treated with SN-38 for 1 h followed by PS-341 for 4 h (SN-38 --> PS-341), or with either drug alone."

16827119

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

SN-38 inhibits NFKBIA. 1 / 1

INDRA sources:

Databases

Reading